Ralph Pelton Robinson, Jr

Title: Ralph Pelton Robinson, Jr.: Innovator in Pharmaceutical Chemistry

Introduction

Ralph Pelton Robinson, Jr. is a notable inventor based in Gales Ferry, CT (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 9 patents. His work primarily focuses on developing compounds that have therapeutic applications, particularly in treating various diseases.

Latest Patents

Among his latest patents is the invention of N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides, which are useful as CCR6 inhibitors. This invention relates to compounds that inhibit CC chemokine receptor 6 (CCR6), along with pharmaceutical compositions containing these compounds. These innovations are aimed at treating or preventing diseases that can be ameliorated by CCR6 inhibition. Another significant patent involves pyrazole derivatives, which are also aimed at medical applications. This invention discusses the use of these derivatives in treating a range of disorders, including sickle cell disease (SCD).

Career Highlights

Ralph Pelton Robinson, Jr. is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to contribute to the development of innovative medical solutions that address critical health issues.

Collaborations

Throughout his career, Robinson has collaborated with talented individuals such as Ariamala Gopalsamy and Arjun Venkat Narayanan. These collaborations have further enhanced the impact of his inventions in the pharmaceutical field.

Conclusion

Ralph Pelton Robinson, Jr. is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in medical treatments. His innovative patents and collaborations continue to influence the industry positively.